396 related articles for article (PubMed ID: 23990460)
1. Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.
Risner LE; Kuntimaddi A; Lokken AA; Achille NJ; Birch NW; Schoenfelt K; Bushweller JH; Zeleznik-Le NJ
J Biol Chem; 2013 Oct; 288(41):29901-10. PubMed ID: 23990460
[TBL] [Abstract][Full Text] [Related]
2. Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia.
Cierpicki T; Risner LE; Grembecka J; Lukasik SM; Popovic R; Omonkowska M; Shultis DD; Zeleznik-Le NJ; Bushweller JH
Nat Struct Mol Biol; 2010 Jan; 17(1):62-8. PubMed ID: 20010842
[TBL] [Abstract][Full Text] [Related]
3. Different binding properties and function of CXXC zinc finger domains in Dnmt1 and Tet1.
Frauer C; Rottach A; Meilinger D; Bultmann S; Fellinger K; Hasenöder S; Wang M; Qin W; Söding J; Spada F; Leonhardt H
PLoS One; 2011 Feb; 6(2):e16627. PubMed ID: 21311766
[TBL] [Abstract][Full Text] [Related]
4. Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein.
Ayton PM; Chen EH; Cleary ML
Mol Cell Biol; 2004 Dec; 24(23):10470-8. PubMed ID: 15542854
[TBL] [Abstract][Full Text] [Related]
5. Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains.
Jørgensen HF; Ben-Porath I; Bird AP
Mol Cell Biol; 2004 Apr; 24(8):3387-95. PubMed ID: 15060159
[TBL] [Abstract][Full Text] [Related]
6. Molecular coupling of DNA methylation and histone methylation.
Hashimoto H; Vertino PM; Cheng X
Epigenomics; 2010 Oct; 2(5):657-69. PubMed ID: 21339843
[TBL] [Abstract][Full Text] [Related]
7. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.
Biswas D; Milne TA; Basrur V; Kim J; Elenitoba-Johnson KS; Allis CD; Roeder RG
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15751-6. PubMed ID: 21896721
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2.
Bach C; Mueller D; Buhl S; Garcia-Cuellar MP; Slany RK
Oncogene; 2009 Feb; 28(6):815-23. PubMed ID: 19060922
[TBL] [Abstract][Full Text] [Related]
9. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.
Muntean AG; Tan J; Sitwala K; Huang Y; Bronstein J; Connelly JA; Basrur V; Elenitoba-Johnson KS; Hess JL
Cancer Cell; 2010 Jun; 17(6):609-21. PubMed ID: 20541477
[TBL] [Abstract][Full Text] [Related]
10. Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential.
Kuntimaddi A; Achille NJ; Thorpe J; Lokken AA; Singh R; Hemenway CS; Adli M; Zeleznik-Le NJ; Bushweller JH
Cell Rep; 2015 May; 11(5):808-20. PubMed ID: 25921540
[TBL] [Abstract][Full Text] [Related]
11. Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase.
Allen MD; Grummitt CG; Hilcenko C; Min SY; Tonkin LM; Johnson CM; Freund SM; Bycroft M; Warren AJ
EMBO J; 2006 Oct; 25(19):4503-12. PubMed ID: 16990798
[TBL] [Abstract][Full Text] [Related]
12. Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms.
Fujita N; Takebayashi S; Okumura K; Kudo S; Chiba T; Saya H; Nakao M
Mol Cell Biol; 1999 Sep; 19(9):6415-26. PubMed ID: 10454587
[TBL] [Abstract][Full Text] [Related]
13. Specificity of MLL1 and TET3 CXXC domains towards naturally occurring cytosine modifications.
Stroynowska-Czerwinska A; Piasecka A; Bochtler M
Biochim Biophys Acta Gene Regul Mech; 2018 Dec; 1861(12):1093-1101. PubMed ID: 30352306
[TBL] [Abstract][Full Text] [Related]
14. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
[TBL] [Abstract][Full Text] [Related]
15. SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.
Ropa J; Saha N; Hu H; Peterson LF; Talpaz M; Muntean AG
Haematologica; 2020 Sep; 105(9):2273-2285. PubMed ID: 33054052
[TBL] [Abstract][Full Text] [Related]
16. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.
Nguyen AT; Taranova O; He J; Zhang Y
Blood; 2011 Jun; 117(25):6912-22. PubMed ID: 21521783
[TBL] [Abstract][Full Text] [Related]
17. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
Milne TA; Martin ME; Brock HW; Slany RK; Hess JL
Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.
Wang WT; Chen TQ; Zeng ZC; Pan Q; Huang W; Han C; Fang K; Sun LY; Yang QQ; Wang D; Luo XQ; Sun YM; Chen YQ
J Hematol Oncol; 2020 Jun; 13(1):78. PubMed ID: 32552847
[TBL] [Abstract][Full Text] [Related]
19. CFP1 interacts with DNMT1 independently of association with the Setd1 Histone H3K4 methyltransferase complexes.
Butler JS; Lee JH; Skalnik DG
DNA Cell Biol; 2008 Oct; 27(10):533-43. PubMed ID: 18680430
[TBL] [Abstract][Full Text] [Related]
20. MLL is essential for NUP98-HOXA9-induced leukemia.
Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
